The following on the treatments of adenocarcinomas in Barrett's esophagus contains commentaries on endo mucosal resection; choice between other ablative therapies; the remaining genetic abnormalities following stepwise endoscopic mucosal resection and possible recurrences; the Fotelo-Fotesi PDT; the CT TNM classification of early stages of Barrett's carcinoma; the indications of lymphadenectomy in intramucosal cancer; the differences in lymph node yield in transthoracic versus transhiatal dissection; video-assisted lymphadenectomy; and the importance of the length of proximal esophageal resectipon; and indications of sentinel node dissection.
Komanduri, S., Deprez, P., Atasoy, A., Hofmann, G., Pokieser, P., Ba-Ssalamah, A., Collard, J.-M., Wijnhoven, B. P., Verhage, R. J. J., Brücher, B., Schuhmacher, C., Feith, M., & Stein, H. (2011). Barrett’s esophagus: treatments of adenocarcinomas I. Annals / New York Academy of Sciences, 1232, 248-264. https://doi.org/10.1111/j.1749-6632.2011.06055.x (Original work published 2011)